Invesco Pharmaceuticals ETF
Open-end / ETFRegistrant
Invesco Exchange-Traded Fund Trust
Class ticker
Net Assets
$472,102,031
Holdings
33
Latest Report
Jul 31, 2026
Net Assets Over Time
Holdings · 33
Export CSV| Holding | Symbol | Balance | Value | % of Fund | Side | Category | Open |
|---|---|---|---|---|---|---|---|
|
Invesco Private Prime Fund
|
— | 37,423,681 | $37,427,423 | 7.93% | Long | STIV | |
| Abbott Laboratories | ABT | 253,317 | $26,775,607 | 5.67% | Long | EC | |
| AbbVie Inc. | ABBV | 103,038 | $25,856,356 | 5.48% | Long | EC | |
| Amgen Inc. | AMGN | 65,359 | $25,173,672 | 5.33% | Long | EC | |
| Johnson & Johnson | JNJ | 95,373 | $24,448,869 | 5.18% | Long | EC | |
| Merck & Co., Inc. | MRK | 183,363 | $23,873,863 | 5.06% | Long | EC | |
| Eli Lilly and Co. | LLY | 20,622 | $23,691,378 | 5.02% | Long | EC | |
| Corcept Therapeutics Inc. | CORT | 204,618 | $23,426,715 | 4.96% | Long | EC | |
| Gilead Sciences, Inc. | GILD | 164,182 | $21,378,138 | 4.53% | Long | EC | |
| Pfizer Inc. | PFE | 849,353 | $21,242,319 | 4.50% | Long | EC | |
| Amneal Pharmaceuticals, Inc. | AMRX | 965,545 | $17,688,784 | 3.75% | Long | EC | |
|
Invesco Private Government Fund
|
— | 17,629,582 | $17,629,582 | 3.73% | Long | STIV | |
| Liquidia Corp. | LQDA | 205,492 | $17,283,932 | 3.66% | Long | EC | |
| Travere Therapeutics, Inc. | TVTX | 278,876 | $15,586,380 | 3.30% | Long | EC | |
| Ligand Pharmaceuticals Inc. | LGND | 52,490 | $15,092,975 | 3.20% | Long | EC | |
| Regeneron Pharmaceuticals, Inc. | REGN | 19,460 | $14,840,780 | 3.14% | Long | EC | |
| Harmony Biosciences Holdings, Inc. | HRMY | 410,448 | $14,464,188 | 3.06% | Long | EC | |
| Bristol-Myers Squibb Co. | BMY | 212,823 | $13,899,470 | 2.94% | Long | EC | |
| Viatris Inc. | VTRS | 759,533 | $13,337,399 | 2.83% | Long | EC | |
| Jazz Pharmaceuticals PLC | JAZZ | 52,047 | $13,160,604 | 2.79% | Long | EC | |
| Biogen Inc. | BIIB | 63,929 | $12,974,391 | 2.75% | Long | EC | |
| Collegium Pharmaceutical, Inc. | COLL | 365,632 | $12,939,716 | 2.74% | Long | EC | |
| Prestige Consumer Healthcare Inc. | PBH | 257,185 | $12,915,831 | 2.74% | Long | EC | |
| Ocular Therapeutix, Inc. | OCUL | 1,489,689 | $12,170,759 | 2.58% | Long | EC | |
| ANI Pharmaceuticals, Inc. | ANIP | 151,712 | $12,021,659 | 2.55% | Long | EC | |
| Tarsus Pharmaceuticals, Inc. | TARS | 201,930 | $11,921,947 | 2.53% | Long | EC | |
| Perrigo Co. PLC | PRGO | 1,143,527 | $11,561,058 | 2.45% | Long | EC | |
|
Supernus Pharmaceuticals, Inc.
|
868459108 | 258,498 | $11,536,766 | 2.44% | Long | EC | |
| Innoviva, Inc. | INVA | 544,496 | $11,418,081 | 2.42% | Long | EC | |
| United Therapeutics Corp. | UTHR | 21,361 | $11,058,803 | 2.34% | Long | EC | |
|
Invesco Government & Agency Portfolio
|
825252885 | 474,555 | $474,555 | 0.10% | Long | STIV | |
|
OmniAb, Inc.
|
68218J301 | 39,023 | $0 | 0.00% | Long | EC | |
|
OmniAb, Inc.
|
68218J202 | 39,023 | $0 | 0.00% | Long | EC |